Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2025-08-06		NCT05690048

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
German Cancer Research Center	47
Heidelberg University	49
Michael Dill	1
National Center for Tumor Diseases, Heidelberg	5
University of Cologne	43
Universitätsmedizin Mannheim	12

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University Hospital Augsburg	Augsburg	Germany	8
University Hospital Essen	Essen	Germany	14
University Hospital Heidelberg	Heidelberg	Germany	5
University Hospital Mannheim	Mannheim	Germany	7
University Hospital Regensburg	Regensburg	Germany	7
University Hospital Tübingen	Tübingen	Germany	14
University Hospital Ulm	Ulm	Germany	17